Skip to Content
Skip to Footer
en-us
italiano
Sign In
Istituto Superiore di Sanità
Follow us on
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
MENU
Istituto Superiore di Sanità
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
Search Results - Home
Search
Search
Asset Entries
Any Asset
Web Content Article
(101)
Tags
Any Tag
iss per covid 19
(2)
faq vaccini
(1)
vaccini
(1)
Time
Any Time
Past Hour
(0)
Past 24 Hours
(0)
Past Week
(0)
Past Month
(15)
Past Year
(52)
Custom Range…
From
To
Search
No results were found that matched the keywords:
Omicron BA 2.75
.
Search
Press Release No. 70/2022 COVID19: ISS Flash Survey, 100%
Omicron
on 4 October, Subvariant...
BA
.5 was predominant, while
BA
.4,
BA
.2 and
BA
.1 were also present
Web Content Article
Leggi la relazione tecnica In Italy on 4 October, the
Omicron
variant had an estimated...These are the estimated prevalences:
BA
.1 0.1% (range: 0% ...
Newsroom:
Press notes
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Press Release No. 57/2022 COVID-19: ISS Flash Survey, on 2 August 100%
Omicron
, 90.8%...Predominance of Subvariant
BA
.5
Web Content Article
Leggi il bollettino ISS, 12 August 2022 In Italy on 2 August, the
Omicron
variant...Estimated prevalence values were as follows: 100%
Omicron
...
Newsroom:
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Press Release No. 08/2022 COVID-19: Flash survey ISS: 95.8% positive
Omicron
samples
Web Content Article
Leggi la flash survey Iss 28 January 2022 - On 17 January, in Italy, the
Omicron
Newsroom:
Press notes
Press releases
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
On January 3
Omicron
-positive samples are 81%
Web Content Article
Leggi la flash survey completa Rome, 14 January 2022 In Italy on 03 January
Omicron
Newsroom:
Press releases
Press notes
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Press Release N°65/2021 A sequence attributable to the
Omicron
variant has been identified
Web Content Article
ISS, November 27th 2021
Newsroom:
Press releases
Press notes
Special on COVID-19
Special on COVID-19 » Varianti del virus
Special on COVID-19 » Varianti del virus » Cosa fa l'ISS Varianti
Press Release No. 68/2022 Pregnancy and Breastfeeding: Update of ISS Guidance for COVID-19 Vaccination
Web Content Article
The booster dose with the bivalent formulation of Comirnaty Original/
Omicron
and...Spikevax Original/
Omicron
mRNA vaccines (fourth dose) is...
Newsroom:
Press notes
Press releases
Special on COVID-19
su acque reflue 9-13 gennaio 2023 conferma la presenza esclusiva della variante
Omicron
..., con prevalenza di BQ.1* e presenza di sottovarianti
BA
.
2.75
e BN.1
Web Content Article
This result comes from the Italian version of this content.
Autonome tra il 9 e il 13 gennaio 2023 conferma la presenza esclusiva della variante
Omicron
...prevalenza della sottovariante BQ.1*, nonché la presenza minoritaria di...
Newsroom:
Special on COVID-19
Special on COVID-19 » Acque reflue
reflue 27 novembre - 2 dicembre 2022 conferma la presenza esclusiva della variante
Omicron
..., con prevalenza di BQ.1* e presenza di sottovarianti XBB.1 e
BA
.
2.75
Web Content Article
This result comes from the Italian version of this content.
27 novembre e il 2 dicembre 2023 conferma la presenza esclusiva della variante
Omicron
...della sottovariante BQ.1*, nonché la presenza minoritaria di sottovarianti XBB.1 e...
Newsroom:
Special on COVID-19
Special on COVID-19 » Acque reflue
8 Entries
Per Page
4
Entries per Page
8
Entries per Page
20
Entries per Page
40
Entries per Page
60
Entries per Page
Showing 1 to 8 of 101 entries.
Previous Page
Page
1
Page
2
Page
3
...
Intermediate Pages Use TAB to navigate.
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Next Page
Hidden